Non-invasive insulin delivery systems have been of global interest. The goal of many studies was to optimize suitable delivery formulation capable of producing comparable insulin bioavailability and safety that match or supersedes conventional delivery by the invasive subcutaneous (SC) injections. Historically, Pfizer marketed the first insulin inhaler Exubera® in 2006 which was later retracted from the market before completing the two years. In recent years, Afrezza®, a new inhalator, and Oral-Lyn™, a buccal spray, have been introduced to the market. While Afrezza® lost the marketing and distribution support from Sanofi, Oral-Lyn™ have not secured US Food and Drug Administration (FDA) and the European Medicines Agency (EMA) marketing appro...
Abstract: The gastrointestinal tract (GIT) is the route of choice for the administration of most dru...
Diabetes Mellitus (DM) is a cluster of metabolic disorders with the shared feature of hyperglycemia...
Background: Insulin therapy is often met with apprehension among diabetic patients due to the inconv...
The Frederick Banting and Charles Best extracted insulin from bovine pancreas in 1922, who received ...
The subcutaneous injection of insulin for the treatment of diabetes mellitus can lead to patient non...
Diabetes mellitus is a chronic metabolic disorder caused via the deficiency of pancreatic hormone in...
Insulin is a hormone made by the pancreas that allows your body to use sugar (glucose) from carbohyd...
Objectives: A review article on novel approaches on oral insulin delivery.Data Sources:Â Review art...
Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective i...
The design of carriers for insulin delivery has recently attracted major research attentions in the ...
Parenteral administration of insulin remains the most common route of administration, causing local ...
Introduction: The morbidity of diabetes mellitus is increasing, and subcutaneous injection of exogen...
Background: Many works are ongoing with the aim of obtaining a more convenient way than the parenter...
The past year demonstrated how developing pharmacological solutions for better ways of insulin subst...
Objective: Insulin is used to manage diabetes mellitus by subcutaneous injections regulary, that has...
Abstract: The gastrointestinal tract (GIT) is the route of choice for the administration of most dru...
Diabetes Mellitus (DM) is a cluster of metabolic disorders with the shared feature of hyperglycemia...
Background: Insulin therapy is often met with apprehension among diabetic patients due to the inconv...
The Frederick Banting and Charles Best extracted insulin from bovine pancreas in 1922, who received ...
The subcutaneous injection of insulin for the treatment of diabetes mellitus can lead to patient non...
Diabetes mellitus is a chronic metabolic disorder caused via the deficiency of pancreatic hormone in...
Insulin is a hormone made by the pancreas that allows your body to use sugar (glucose) from carbohyd...
Objectives: A review article on novel approaches on oral insulin delivery.Data Sources:Â Review art...
Insulin is a key player in the control of hyperglycemia for type 1 diabetes patients and selective i...
The design of carriers for insulin delivery has recently attracted major research attentions in the ...
Parenteral administration of insulin remains the most common route of administration, causing local ...
Introduction: The morbidity of diabetes mellitus is increasing, and subcutaneous injection of exogen...
Background: Many works are ongoing with the aim of obtaining a more convenient way than the parenter...
The past year demonstrated how developing pharmacological solutions for better ways of insulin subst...
Objective: Insulin is used to manage diabetes mellitus by subcutaneous injections regulary, that has...
Abstract: The gastrointestinal tract (GIT) is the route of choice for the administration of most dru...
Diabetes Mellitus (DM) is a cluster of metabolic disorders with the shared feature of hyperglycemia...
Background: Insulin therapy is often met with apprehension among diabetic patients due to the inconv...